Logo Image
News
OncClubAll Oncology NewsClinical Trials in Focus
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Conference CoverageConference Listing
Events
Giants of Cancer CareCME/CEScientific InterchangesState of the Science SummitNational Fellows ForumWebinars
More
Partners
Publications
All PublicationsSupplements
Resources
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker Consortium

Subscribe

  • News
  • Watch
  • Conferences
  • Events
  • Partners
  • Publications
  • Resources
  • Biomarker Consortium
  • Subscribe
  • AI for Oncology
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
    • HER2+ Breast Cancer
  • CAR T-Cell Therapy
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
    • Pancreatic Cancer
    • Hepatocellular Carcinoma
    • Gastric Cancer
    • Colorectal Cancer
  • Genitourinary Cancers
    • Urothelial Cancer
    • Prostate Cancer
  • Global Oncology
  • Graft-vs-Host Disease
  • Gynecologic Oncology
    • Ovarian Cancer
  • Head & Neck Cancers
  • Hematologic Oncology
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Neoplasms
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Oncology Business Management
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Sarcomas
  • Supportive Care
Spotlight -
The OncLive Insider app is live!|
CME Opportunities
Advertisement

Ryan Nguyen, DO

Advertisement

Articles by Ryan Nguyen, DO

Ryan Nguyen, DO, of the University of Illinois Cancer Center

Dr. Nguyen on Enrollment Disparities in Pivotal Clinical Trials in Oncology

ByRyan Nguyen, DO
June 23rd 2021

Ryan Nguyen, DO, discusses enrollment disparities in pivotal clinical trials in oncology.

Ryan Nguyen, DO, hematology/oncology fellow at the University of Illinois College of Medicine

Telehealth Is Here to Stay: Opportunities and Challenges for Cancer Care

ByRyan Nguyen, DO,Shikha Jain, MD
October 20th 2020

Oncology practices across the United States have rapidly increased telehealth use in 2020 to mitigate the risk of coronavirus disease 2019 (COVID-19) to patients with cancer who are at particular risk of complications.

Advertisement

Latest Updated Articles

  • Ryan Nguyen, DO, of the University of Illinois Cancer Center
    Dr. Nguyen on Enrollment Disparities in Pivotal Clinical Trials in Oncology

    June 23rd 2021

  • Ryan Nguyen, DO, hematology/oncology fellow at the University of Illinois College of Medicine
    Telehealth Is Here to Stay: Opportunities and Challenges for Cancer Care

    October 20th 2020



Advertisement
Advertisement

Trending on OncLive

1

FDA Approves Tucatinib Plus Trastuzumab/Pertuzumab as First-Line Maintenance in Advanced HER2+ Breast Cancer

2

FDA Grants Breakthrough Therapy Designation to Temab-A in Previously Treated c-Met–Expressing Nonsquamous NSCLC

3

September Roundup of FDA Approvals in Oncology: 8 Decisions to Know

4

Two Dana-Farber Researchers Receive Prestigious New Innovator Award from the National Institutes of Health

5

Individualized Neoantigen Vaccine Elicits Durable T-Cell Responses in Resected HPV– HNSCC

  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo
Download on Apple
Download on Google Play

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us